PL3068384T3 - Kompleksy żelaza do zmniejszania kolonizacji przewodu pokarmowego przez campylobacter - Google Patents

Kompleksy żelaza do zmniejszania kolonizacji przewodu pokarmowego przez campylobacter

Info

Publication number
PL3068384T3
PL3068384T3 PL13709500T PL13709500T PL3068384T3 PL 3068384 T3 PL3068384 T3 PL 3068384T3 PL 13709500 T PL13709500 T PL 13709500T PL 13709500 T PL13709500 T PL 13709500T PL 3068384 T3 PL3068384 T3 PL 3068384T3
Authority
PL
Poland
Prior art keywords
campylobacter
reduction
gastrointestinal tract
iron complexes
colonisation
Prior art date
Application number
PL13709500T
Other languages
English (en)
Inventor
Jafar Mahdavi
Aldeen Dlawer Ala'
Original Assignee
Akeso Biomedical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1202681.1A external-priority patent/GB201202681D0/en
Priority claimed from GBGB1220158.8A external-priority patent/GB201220158D0/en
Application filed by Akeso Biomedical Inc filed Critical Akeso Biomedical Inc
Publication of PL3068384T3 publication Critical patent/PL3068384T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • A61K31/295Iron group metal compounds
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/111Aromatic compounds
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/142Amino acids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/70Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75Feeding-stuffs specially adapted for particular animals for birds for poultry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/132Amines having two or more amino groups, e.g. spermidine, putrescine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/164Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/191Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/555Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/661Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18Testing for antimicrobial activity of a material
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL13709500T 2012-02-16 2013-02-15 Kompleksy żelaza do zmniejszania kolonizacji przewodu pokarmowego przez campylobacter PL3068384T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB1202681.1A GB201202681D0 (en) 2012-02-16 2012-02-16 Reduction of gastrointestinal tract colonisation by campylobacter
GBGB1220158.8A GB201220158D0 (en) 2012-11-08 2012-11-08 Reduction of gastrointestinal tract colonisation by campylobacter
EP13709500.6A EP3068384B1 (en) 2012-02-16 2013-02-15 Iron complexes for the reduction of gastrointestinal tract colonisation by campylobacter
PCT/GB2013/050367 WO2013121214A1 (en) 2012-02-16 2013-02-15 Reduction of gastrointestinal tract colonisation by campylobacter

Publications (1)

Publication Number Publication Date
PL3068384T3 true PL3068384T3 (pl) 2019-11-29

Family

ID=47884392

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13709500T PL3068384T3 (pl) 2012-02-16 2013-02-15 Kompleksy żelaza do zmniejszania kolonizacji przewodu pokarmowego przez campylobacter

Country Status (9)

Country Link
US (4) US9655912B2 (pl)
EP (2) EP3569230A1 (pl)
CN (2) CN108524524B (pl)
BR (1) BR112014020171B1 (pl)
CA (1) CA2901407C (pl)
DK (1) DK3068384T3 (pl)
ES (1) ES2738632T3 (pl)
PL (1) PL3068384T3 (pl)
WO (1) WO2013121214A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2966909T3 (es) * 2014-08-13 2024-04-25 Akeso Biomedical Inc Compuestos y composiciones antimicrobianos, y usos de los mismos
US10653658B2 (en) * 2015-08-11 2020-05-19 Akeso Biomedical, Inc. Biofilm inhibiting compositions enhancing weight gain in livestock
US10555531B2 (en) 2015-08-11 2020-02-11 Akeso Biomedical, Inc. Biofilm inhibiting compositions enhancing weight gain in livestock
PT3672421T (pt) 2017-08-24 2020-11-25 Evonik Operations Gmbh Redução da colonização do trato gastrointestinal por campylobacter
NL2022942B1 (en) * 2019-04-15 2020-10-22 Intracare Bv Use of iron chelate to reduce gastrointestinal tract colonisation by campylobacter
CN110218160B (zh) * 2019-06-19 2022-05-24 暨南大学 一种奎宁酸衍生物及其制备方法与应用
EP4552495A1 (en) 2023-11-08 2025-05-14 Stiftung Tierärztliche Hochschule Hannover Additive composition for bacterial load reduction

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2049553A (en) 1926-11-24 1936-08-04 Raytheon Mfg Co Electrical condenser
US4394451A (en) * 1980-10-30 1983-07-19 Biomagnetech Corp. Culture medium and conditions for growth of magnetic bacteria
US6024979A (en) 1995-06-06 2000-02-15 Solvay Animal Health, Inc. Oral veterinary composition containing a fluoroquinolone antibacterial agent possessing superior absorption properties and an extended duration of therapeutic antimicrobial blood levels, and a method of treating a microbial infection in a ruminant
US6242009B1 (en) * 1999-04-20 2001-06-05 Kareem I. Batarseh Microbicidal formulations and methods to control microorganisms
US7431939B1 (en) 2000-09-28 2008-10-07 Mississippi State University Inhibition of systemic infections in humans and vertebrates by dietary fibers
SE0103695D0 (sv) * 2001-11-07 2001-11-07 Thomas Boren A novel non-antibiotic strategy against OGIP infections based on a cereal product
EP1689348B1 (en) * 2003-12-05 2013-05-15 Children's Hospital Medical Center Oligosaccharide compositions and use thereof in the treatment of infection
ATE513025T1 (de) 2004-10-20 2011-07-15 Valspar Sourcing Inc Beschichtungszusammensetzungen für dosen und beschichtungsverfahren
GB0423681D0 (en) * 2004-10-26 2004-11-24 Sec Dep For Environment Food & Vaccine and nucleic acids
JP2006321776A (ja) 2005-05-18 2006-11-30 Kyuuken:Kk アミノ酸を配位して成る金属錯体である抗菌防カビ剤とその二次製品
US20070269495A1 (en) * 2006-05-18 2007-11-22 Ashmead H Dewayne Compositions and methods for enhancing mineral levels in animals with reduced environmental impact
BRPI1013053A2 (pt) 2009-06-08 2016-04-05 Idemitsu Kosan Co agente de controle de coccidiose para um animal, aditivo para ração, método para a criação de um animal, e, líquido aquecido da castanha de caju e/ou cardanol
WO2012034032A2 (en) 2010-09-10 2012-03-15 The Board Of Regents Of Unbiversity Of Texas System Antimicrobial solutions

Also Published As

Publication number Publication date
ES2738632T3 (es) 2020-01-24
DK3068384T3 (da) 2019-08-12
CN104244940A (zh) 2014-12-24
BR112014020171B1 (pt) 2021-12-21
US9655912B2 (en) 2017-05-23
US10195172B2 (en) 2019-02-05
EP3068384A1 (en) 2016-09-21
CN104244940B (zh) 2018-07-20
US20150025026A1 (en) 2015-01-22
US20170231945A1 (en) 2017-08-17
CA2901407C (en) 2021-11-23
CN108524524B (zh) 2021-03-19
WO2013121214A1 (en) 2013-08-22
CN108524524A (zh) 2018-09-14
BR112014020171A2 (pt) 2018-04-10
CA2901407A1 (en) 2013-08-22
EP3569230A1 (en) 2019-11-20
EP3068384B1 (en) 2019-05-08
US20190083447A1 (en) 2019-03-21
US20190314323A1 (en) 2019-10-17

Similar Documents

Publication Publication Date Title
IL234083A0 (en) A pill for the digestive tract
IL236945A0 (en) The hexacyanides of iron have high solubility
HUE052036T2 (hu) Vasat tartalmazó szilárd készítmény vashiányos állapotokban történõ kezelésre
IL221416A0 (en) Alpha-emititng complexes
GB201208309D0 (en) Complexes
GB201321559D0 (en) Diagnosis of the condition of apparatus
PT2585216T (pt) Complexos de п-alilpaládio e п-alilníquel para utilização como catalisadores em reações de acoplamento de carbono-carbono e carbono-azoto
SMT201700362T1 (it) Biosensore comprendente nanoparticelle metalliche
PL2536742T3 (pl) Leczenie zaburzeń żołądkowo-jelitowych
PL3068384T3 (pl) Kompleksy żelaza do zmniejszania kolonizacji przewodu pokarmowego przez campylobacter
GB2508667B (en) Diagnosis of the condition of apparatus
SG11201501382YA (en) Nanoparticulate contrast agent
IL230904A0 (en) A process for making a radioactive isotope of gallium
EP2928915A4 (en) FGF-10 COMPLEX
GB201003483D0 (en) Gold complexes
GB2507052B (en) Interference reduction
GB2519447B (en) Biosensors
PL2855475T3 (pl) Alfa-karboliny do leczenia nowotworu
EP2883968A4 (en) AGGLOMERATION DEVICE FOR DIRECT-REDUCED IRON
SI2650390T1 (sl) Peč navijalnika
GB201104522D0 (en) Complexes
GB201220158D0 (en) Reduction of gastrointestinal tract colonisation by campylobacter
GB201202681D0 (en) Reduction of gastrointestinal tract colonisation by campylobacter
PT2692355T (pt) Apolactoferrina para o tratamento de doenças por acumulação de ferro
IL221369A0 (en) Pharmaceutical composition for treating the gastrointestinal tract